An evaluation of different Cripto‐1 antibodies and their variable results
- 16 July 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (1) , 545-556
Abstract
Cripto‐1 is a protein expressed during embryonal development and has been linked to several malignant processes in cancer. Since the discovery of cripto‐1 in the late 1980s, it has become a subject of biomarker investigation in several types of cancer which in many cases relies on immunolocalization of cripto‐1 using antibodies. Investigating cripto‐1 expression and localization in primary glioblastoma cells, we discovered nonspecific binding of cripto‐1 antibody to the extracellular matrix Geltrex. A panel of four cripto‐1 antibodies was investigated with respect to their binding to the Geltrex matrix and to the cripto‐1 positive control cells NTERA2. The cripto‐1 expression was varied for the different antibodies with respect to cellular localization and fixation methods. To further elaborate on these findings, we present a systematic review of cripto‐1 antibodies found in the literature and highlight some possible cross reactants with data on sequence alignments and structural comparison of EGF domains.Keywords
This publication has 63 references indexed in Scilit:
- On the reproducibility of science: unique identification of research resources in the biomedical literaturePeerJ, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and CancerThe American Journal of Pathology, 2012
- Specificity Controls for ImmunocytochemistryJournal of Histochemistry & Cytochemistry, 2012
- Role of Cripto-1 in Stem Cell Maintenance and Malignant ProgressionThe American Journal of Pathology, 2010
- Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1Journal of Cell Biology, 2009
- Regulation of Cripto-1 Signaling and Biological Activity by Caveolin-1 in Mammary Epithelial CellsThe American Journal of Pathology, 2008
- GRP78 and Cripto Form a Complex at the Cell Surface and Collaborate To Inhibit Transforming Growth Factor β Signaling and Enhance Cell GrowthMolecular and Cellular Biology, 2008
- Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β SignalingMolecular and Cellular Biology, 2006
- Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor CriptoGenes & Development, 2003